“Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020040, Jun. 2020, doi: 10.4084/mjhid.2020.040.